CONCERT PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CONCERT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CONCERT PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 391,359 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 1,956,794 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 1,467,595 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 8,641 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 43,206 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 32,405 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | P | 14.00 | 101,264 | 1,417,696 | 801,726 | 700.5 K to 801.7 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | P | 14.00 | 2,236 | 31,304 | 17,701 | 15.5 K to 17.7 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 69,267 | 0 | 700,462 | 631.2 K to 700.5 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 346,335 | 0 | 631,195 | 284.9 K to 631.2 K (+121.58 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 259,751 | 0 | 284,860 | 25.1 K to 284.9 K (+1,034.49 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 1,529 | 0 | 15,465 | 13.9 K to 15.5 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 7,647 | 0 | 13,936 | 6.3 K to 13.9 K (+121.59 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 5,735 | 0 | 6,289 | 554 to 6.3 K (+1,035.20 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 379,592 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 1,897,959 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 1,423,469 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 20,408 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 102,041 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Option Exercise | C | 0.00 | 76,531 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | P | 14.00 | 98,219 | 1,375,066 | 777,620 | 679.4 K to 777.6 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | P | 14.00 | 5,281 | 73,934 | 41,807 | 36.5 K to 41.8 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 67,184 | 0 | 679,401 | 612.2 K to 679.4 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 335,922 | 0 | 612,217 | 276.3 K to 612.2 K (+121.58 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 251,941 | 0 | 276,295 | 24.4 K to 276.3 K (+1,034.50 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 3,612 | 0 | 36,526 | 32.9 K to 36.5 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 18,060 | 0 | 32,914 | 14.9 K to 32.9 K (+121.58 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | THREE ARCH MANAGEMENT III LLC | Director | Buy | C | 0.00 | 13,545 | 0 | 14,854 | 1.3 K to 14.9 K (+1,034.76 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | QVT Associates GP LLC | 10% Owner | Option Exercise | C | 0.00 | 219,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | QVT Associates GP LLC | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | QVT Associates GP LLC | 10% Owner | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | QVT Associates GP LLC | 10% Owner | Buy | P | 14.00 | 300,000 | 4,200,000 | 559,999 | 260 K to 560 K (+115.39 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | QVT Associates GP LLC | 10% Owner | Buy | C | 0.00 | 259,999 | 0 | 259,999 | 0 to 260 K |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | BROOKSIDE CAPITAL MANAGEMENT L ... | 10% Owner | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | BROOKSIDE CAPITAL MANAGEMENT L ... | 10% Owner | Option Exercise | C | 0.00 | 4,300,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | BROOKSIDE CAPITAL MANAGEMENT L ... | 10% Owner | Buy | P | 14.00 | 350,000 | 4,900,000 | 1,497,833 | 1.1 M to 1.5 M (+30.49 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | BROOKSIDE CAPITAL MANAGEMENT L ... | 10% Owner | Buy | C | 0.00 | 353,982 | 0 | 1,147,833 | 793.9 K to 1.1 M (+44.59 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | BROOKSIDE CAPITAL MANAGEMENT L ... | 10% Owner | Buy | C | 0.00 | 761,062 | 0 | 793,851 | 32.8 K to 793.9 K (+2,321.09 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 2,200,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Buy | P | 14.00 | 150,000 | 2,100,000 | 1,208,920 | 1.1 M to 1.2 M (+14.17 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Buy | C | 0.00 | 106,194 | 0 | 1,058,920 | 952.7 K to 1.1 M (+11.15 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Buy | C | 0.00 | 530,974 | 0 | 952,726 | 421.8 K to 952.7 K (+125.90 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Freund John Gordon | Director | Buy | C | 0.00 | 389,380 | 0 | 421,752 | 32.4 K to 421.8 K (+1,202.83 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 2,200,000 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | P | 14.00 | 150,000 | 2,100,000 | 1,208,920 | 1.1 M to 1.2 M (+14.17 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 106,194 | 0 | 1,058,920 | 952.7 K to 1.1 M (+11.15 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 530,974 | 0 | 952,726 | 421.8 K to 952.7 K (+125.90 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 389,380 | 0 | 421,752 | 32.4 K to 421.8 K (+1,202.83 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | New Leaf Ventures I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 77,522 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | New Leaf Ventures I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 442,478 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | New Leaf Ventures I, L.P. | 10% Owner | Buy | C | 0.00 | 13,721 | 0 | 107,327 | 93.6 K to 107.3 K (+14.66 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | New Leaf Ventures I, L.P. | 10% Owner | Buy | C | 0.00 | 78,315 | 0 | 93,606 | 15.3 K to 93.6 K (+512.16 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 288,407 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 1,084,813 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 561,550 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 841,493 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 3,165,187 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 1,638,450 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 14.00 | 22,713 | 317,982 | 378,703 | 356 K to 378.7 K (+6.38 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 14.00 | 66,287 | 928,018 | 1,104,969 | 1 M to 1.1 M (+6.38 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 51,045 | 0 | 355,990 | 304.9 K to 356 K (+16.74 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 192,003 | 0 | 304,945 | 112.9 K to 304.9 K (+170.00 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 99,389 | 0 | 112,942 | 13.6 K to 112.9 K (+733.34 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 148,936 | 0 | 1,038,682 | 889.7 K to 1 M (+16.74 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 560,211 | 0 | 889,746 | 329.5 K to 889.7 K (+170.00 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 289,991 | 0 | 329,535 | 39.5 K to 329.5 K (+733.34 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 6,666,667 | 0 | 0 | ||
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | ||
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | GLAXOSMITHKLINE PLC | Buy | P | 14.00 | 35,000 | 490,000 | 1,356,533 | 1.3 M to 1.4 M (+2.65 %) | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 1,179,941 | 0 | 1,321,533 | 141.6 K to 1.3 M (+833.34 %) | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 141,592 | 0 | 141,592 | 0 to 141.6 K | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | Adage Capital Partners, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,800,000 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | Adage Capital Partners, L.P. | 10% Owner | Buy | C | 0.00 | 495,575 | 0 | 510,147 | 14.6 K to 510.1 K (+3,400.87 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Daws D. Ryan | Chief Financial Off ... | Option Exercise | A | 14.09 | 123,893 | 1,745,652 | 123,893 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Buy | C | 0.00 | 4,424 | 0 | 13,274 | 8.9 K to 13.3 K (+49.99 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Buy | C | 0.00 | 8,850 | 0 | 8,850 | 0 to 8.9 K |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Tung Roger D | Chief Executive Off ... | Buy | C | 0.00 | 17,699 | 0 | 401,522 | 383.8 K to 401.5 K (+4.61 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | HUTT PETER BARTON | Director | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | HUTT PETER BARTON | Director | Buy | C | 0.00 | 4,424 | 0 | 4,424 | 0 to 4.4 K |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 38,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 190,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 152,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 342,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 1,710,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Option Exercise | C | 0.00 | 1,368,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 6,725 | 0 | 67,256 | 60.5 K to 67.3 K (+11.11 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 33,629 | 0 | 60,531 | 26.9 K to 60.5 K (+125.01 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 26,902 | 0 | 26,902 | 0 to 26.9 K |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 60,530 | 0 | 605,309 | 544.8 K to 605.3 K (+11.11 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 302,655 | 0 | 544,779 | 242.1 K to 544.8 K (+125.00 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Greylock XII GP LLC | 10% Owner | Buy | C | 0.00 | 242,124 | 0 | 242,124 | 0 to 242.1 K |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 525,500 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 93,008 | 0 | 656,490 | 563.5 K to 656.5 K (+16.51 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 530,974 | 0 | 563,482 | 32.5 K to 563.5 K (+1,633.36 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | ALDRICH RICHARD | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | ALDRICH RICHARD | Director | Option Exercise | C | 0.00 | 300,000 | 0 | 0 | |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | ALDRICH RICHARD | Director | Buy | C | 0.00 | 8,849 | 0 | 61,946 | 53.1 K to 61.9 K (+16.67 %) |
| Feb 19 2014 | CNCE | CONCERT PHARMACEUT ... | ALDRICH RICHARD | Director | Buy | C | 0.00 | 53,097 | 0 | 53,097 | 0 to 53.1 K |